Modern Treatment of Schizophrenia
We recommend
Metabolická a kardiovaskulární rizika u pacientů se schizofrenií
Pacienti se schizofrenií mají oproti obecné populaci vyšší prevalenci kardiometabolických (KM) rizikových faktorů, což přispívá k jejich vyšší mortalitě. Vedle vrozených dispozic, nezdravého životního stylu a snížené dostupnosti lékařské péče může KM riziko zvyšovat rovněž antipsychotická léčba. Psychiatr může ke snížení tohoto rizika přispět monitorováním tělesného zdraví svých pacientů a případnou léčbou ve spolupráci s dalšími specialisty a také výběrem méně rizikového antipsychotika.
Improvement in social functioning of patients with schizophrenia during treatment with lurasidone
A beneficial impact on social functioning is an important outcome of schizophrenia treatment. A…
Causes, Consequences, and Solutions to Weight Gain in Schizophrenia Treatment
The use of antipsychotics in the treatment of schizophrenia is often associated with the…
Articles on this topic
Lurasidone in a Patient with Paranoid Schizophrenia and Asperger's Syndrome – A Case Study
Lurasidone is an effective and very gentle antipsychotic which is establishing a prominent…
Augmentation of Clozapine with Lurasidone in Resistant Schizophrenia in Real Practice
Treatment-resistant schizophrenia remains a clinical and pharmacological challenge. Clozapine…
How do body weight and metabolic parameters change in patients first hospitalized for psychosis?
The most common cause of death in patients with schizophrenia is cardiovascular disease, which…
Side Effects of Antipsychotics and Patient Preferences in the Treatment of Schizophrenia
Although a number of antipsychotics are currently available, many patients still suffer from…
Sequential Treatment of Schizophrenia – Interactive Case Study
Sequential treatment of schizophrenia helps psychiatrists clarify the stage of the patient's treatment...
Treatment of Schizophrenia in a Patient at Risk of Developing Metabolic Syndrome – Interactive Case Study
A 34-year-old man has been under psychiatric care for 3 years due to a psychotic disorder. Three...
“Customized Schizophrenia Treatment”: Benefits of Therapeutic Innovations in Inpatient and Outpatient Care Thanks to Gentler Antipsychotics
In the field of schizophrenia treatment, the possibility of significantly greater…
What are the patients' needs during acute phase schizophrenia therapy and how to increase their adherence?
Treatment of an acute episode of schizophrenia usually requires hospitalization in a…
Summary of Czech Recommendations for the Diagnosis and Treatment of Schizophrenia in Children and Adolescents 2022
In June 2022, the Psychiatric Society of the Czech Medical Association JEP updated its…
Impact of Administering Omega-3 Fatty Acids on the Risk of Metabolic Syndrome in Patients with Schizophrenia
The aim of the Polish clinical study OFFER was to assess the possibility of influencing the…
1
2
Subscribe
E-courses on this topic
Conferences news
Go to records
Go to records
Go to records
Most read on this topic
- Education in schizophrenia: How patients and their relatives assess the relapse prevention programme PREDUKA
- Are risk factors in prenatal and perinatal period important for develompent of schizophrenia?
- Diabetes and Schizophrenia
- Sequential Treatment of Schizophrenia – Interactive Case Study
- Treatment of Schizophrenia in a Patient at Risk of Developing Metabolic Syndrome – Interactive Case Study
- Lurasidone in a Patient with Paranoid Schizophrenia and Asperger's Syndrome – A Case Study
Journal on this topic
Related topic